Role of modern imaging techniques for diagnosis of infection in the era of 18F-fluorodeoxyglucose positron emission tomography

Clinical Microbiology Reviews

Volumn 21, Issue 1, 2008, Pages 209-224

  Kumar, Rakesh ^a   Basu, Sandip ^b   Torigian, Drew ^b   Anand, Vivek ^a   Zhuang, Hongming ^b,c   Alavi, Abass ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC THERAPY; BONE INFECTION; BONE SCINTISCANNING; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ECHINOCOCCOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; LIVER CYST; LUNG ABSCESS; OSTEOMYELITIS; PATHOLOGICAL ANATOMY; PNEUMOCYSTOSIS; POSITRON EMISSION TOMOGRAPHY; PROSTHESIS INFECTION; REVIEW; SOFT TISSUE INFECTION; TREATMENT RESPONSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BONE DISEASES, INFECTIOUS; COMMUNICABLE DISEASES; DIABETIC FOOT; FEVER OF UNKNOWN ORIGIN; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; PROSTHESIS-RELATED INFECTIONS; SOFT TISSUE INFECTIONS; TREATMENT OUTCOME;

EID: 38549092633     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.00025-07     Document Type: Review

References (184)

1. Adams, B. K., I. Youssef, and S. Parkar. 2006. Absent Tc-99m ciprofloxacin (Infecton) uptake in a renal abscess. Clin. Nucl. Med. 31:211-212.
2. Alavi, A., C. A. Buchpiguel, and A. Loessner. 1994. Is there a role for FDG PET imaging in the management of patients with sarcoidosis? J. Nucl. Med. 35:1650-1652.
3. Alavi, A., R. Dann, J. Chawluk, J. Alavi, M. Kushner, and M. Reivich. 1986. Positron emission tomography imaging of regional cerebral glucose metabolism. Semin. Nucl. Med. 16:2-34.
4. Alavi, A., E. Kramer, W. Wegener, and J. Alavi. 1990. Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor. J. Nucl. Med. 31:360-364.
5. Alavi, A., P. Lakhani, A. Mavi, J. W. Kung, and H. Zhuang. 2004. PET: a revolution in medical imaging. Radiol. Clin. N. Am. 42:983-1001.
6. Alavi, A., A. B. Newberg, E. Souder, and J. A. Berlin. 1993. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators. J. Nucl. Med. 34:1681-1687.
7. Alavi, A., and M. Reivich. 2002. The conception of FDG-PET imaging. Semin. Nucl. Med. 32:2-5.
8. Alavi, A., M. Reivich, S. Ferris, D. Christman, J. Fowler, R. MacGregor, T. Farkas, J. Greenberg, R. Dann, and A. Wolf. 1982. Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. Exp. Brain. Res. Suppl. 5:187-195.
9. Allen, S., J. Todd, S. Copley, and A. Al-Nahhas. 2005. F-18 FDG uptake in bilateral pulmonary artery leiomyosarcomata, one mimicking a pulmonary embolus. Clin. Nucl. Med. 30:418-419.
10. Andrews, J., and J. C. Mason. 2007. Takayasu's arteritis - recent advances in imaging offer promise. Rheumatology (Oxford) 46:6-15.
11. Aydin, A., M. Hickeson, J. Q. Yu, H. Zhuang, and A. Alavi. 2005. Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease. Clin. Nucl. Med. 30:159-164.
12. Basu, S., T. Chryssikos, M. Houseni, D. S. Malay, J. Shah, H. M. Zhuang, and A. Alavi. 2007. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl. Med. Commun. 28:465-472.
13. Bennink, R. J., M. Peeters, P. Rutgeerts, and L. Mortelmans. 2004. Evaluation of early treatment response and predicting the need for colectomy in active ulcerative colitis with 99mTc-HMPAO white blood cell scintigraphy. J. Nucl. Med. 45:1698-1704.
14. Bhargava, P., E. Glass, and M. Ghesani. 2006. Inflammatory F-18 FDG uptake secondary to ruptured breast prosthesis. Clin. Nucl. Med. 31:227-228.
15. Biggar, R. J., and C. S. Rabkin. 1996. The epidemiology of AIDS-related neoplasms. Hematol. Oncol. Clin. N. Am. 10:997-1010.
16. Bleeker-Rovers, C. P., S. J. Bredie, J. W. van der Meer, F. H. Corstens, and W. J. Oyen. 2003. F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. Neth. J. Med. 61:323-329.
17. Bleeker-Rovers, C. P., E. M. de Kleijn, F. H. Corstens, J. W. van der Meer, and W. J. Oyen. 2004. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur. J. Nucl. Med. Mol. Imaging 31:29-37.
18. Bleeker-Rovers, C. P., R. G. de Sevaux, H. W. van Hamersvelt, F. H. Corstens, and W. J. Oyen. 2003. Diagnosis of renal and hepatic cyst infections by 18-F-fluorodeoxyglucose positron emission tomography in autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 41:E18-21.
19. Bleeker-Rovers, C. P., A. Warris, J. P. Drenth, F. H. Corstens, W. J. Oyen, and B. J. Kullberg. 2005. Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography. Clin. Microbiol. Infect. 11:493-495.
20. Blockmans, D., D. Knockaert, A. Maes, J. De Caestecker, S. Stroobants, H. Bobbaers, and L. Mortelmans. 2001. Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin. Infect. Dis. 32:191-196.
21. Boulton, A. J., and L. Vileikyte. 2000. The diabetic foot: the scope of the problem. J. Fam. Pract. 49:S3-8.
22. Britton, K. E., D. W. Wareham, S. S. Das, K. K. Solanki, H. Amaral, A. Bhatnagar, A. H. Katamihardja, J. Malamitsi, H. M. Moustafa, V. E. Soroa, F. X. Sundram, and A. K. Padhy. 2002. Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). J. Clin. Pathol. 55:817-823.
23. Brodmann, M., R. W. Lipp, A. Passath, G. Seinost, E. Pabst, and E. Pilger. 2004. The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43:241-242.
24. Brust, D., M. Polis, R. Davey, B. Hahn, S. Bacharach, M. Whatley, A. S. Fauci, and J. A. Carrasquillo. 2006. Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS 20:495-503.
25. Chacko, T. K., H. Zhuang, K. Z. Nakhoda, B. Moussavian, and A. Alavi. 2003. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl. Med. Commun. 24:615-624.
26. Chacko, T. K., H. Zhuang, K. Stevenson, B. Moussavian, and A. Alavi. 2002. The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses. Nucl. Med. Commun. 23:851-855.
27. Chakrabarti, R., C. Y. Jung, T. P. Lee, H. Liu, and B. K. Mookerjee. 1994. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemagglutinin. J. Immunol. 152:2660-2668.
28. Chamroonrat, W., H. Zhuang, M. Houseni, A. Mavi, G. El-Haddad, C. Bhutain, and A. Alavi. 2006. Malignant lesions can mimic gastric uptake on FDG PET. Clin. Nucl. Med. 31:37-38.
29. Chan, E. D., L. S. Terada, and M. I. Schwarz. 1995. Sarcoidosis presenting with prolonged fever in a patient with sickle cell anemia. J. Natl. Med. Assoc. 87:826-828.
30. Chang, C. Y., Y. M. Fan, C. Y. Bai, and S. C. Cherng. 2006. Schwannoma mimicking lung cancer metastases demonstrated by PET/CT. Clin. Nucl. Med. 31:644-645.
31. Chatha, D. S., P. M. Cunningham, and M. E. Schweitzer. 2005. MR imaging of the diabetic foot: diagnostic challenges. Radiol. Clin. N. Am. 43:747-759.
32. Chen, D. L., T. W. Ferkol, M. A. Mintun, J. E. Pittman, D. B. Rosenbluth, and D. P. Schuster. 2006. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am. J. Respir. Crit. Care Med. 173:1363-1369.
33. Conrad, G. R., and P. Sinha. 2003. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy. Nucl. Med. Commun. 24:1129-1137.
34. Cunha, B. A., S. Parchuri, and S. Mohan. 2006. Fever of unknown origin: temporal arteritis presenting with persistent cough and elevated serum ferritin levels. Heart Lung 35:112-116.
35. Dadparvar, S., G. S. Anderson, P. Bhargava, L. Guan, P. Reich, A. Alavi, and H. Zhuang. 2003. Paraneoplastic encephalitis associated with cystic teratoma is detected by fluorodeoxyglucose positron emission tomography with negative magnetic resonance image findings. Clin. Nucl. Med. 28:893-896.
36. Daniel, B. L., J. P. Crabbe, L. Glitters, and B. Shapiro. 1993. Bone scintigraphy in blastomycotic osteomyelitis. Clin. Nucl. Med. 18:203-207.
37. Defawe, O. D., R. Hustinx, J. O. Defraigne, R. Limet, and N. Sakalihasan. 2005. Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: high accumulation in macrophages seen on PET imaging and immunohistology. Clin. Nucl. Med. 30:340-341.
38. de Kleijn, E. M., and J. W. van der Meer. 1995. Fever of unknown origin (FUO): report on 53 patients in a Dutch university hospital. Neth. J. Med. 47:54-60.
39. de Leeuw, K., M. Bijl, and P. L. Jager. 2004. Additional value of positron emission tomography in diagnosis and follow-up of patients with large vessel vasculitides. Clin. Exp. Rheumatol. 22:S21-26.
40. de Winter, F., C. van de Wiele, D. Vogelaers, K. de Smet, R. Verdonk, and R. A. Dierckx. 2001. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J. Bone Joint Surg. Am. 83-A:651-660.
41. De Winter, F., D. Vogelaers, F. Gemmel, and R. A. Dierckx. 2002. Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases. Eur. J. Clin. Microbiol. Infect. Dis. 21:247-257.
42. Dumarey, N., D. Egrise, D. Blocklet, B. Stallenberg, M. Remmelink, V. del Marmol, G. Van Simaeys, F. Jacobs, and S. Goldman. 2006. Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J. Nucl. Med. 47:625-632.
43. Ehrhardt, A. R., S. Reuter, A. K. Buck, M. M. Haenle, R. A. Mason, A. Gabelmann, P. Kern, and W. Kratzer. 7 February 2007, posting date. Assessment of disease activity in alveolar echinococcosis: a comparison of contrast enhanced ultrasound, three-phase helical CT and [(18)F] fluorodeoxyglucose positron emission tomography. Abdom. Imaging [Epub ahead of print]. doi:10.1007/s00261-006-9173-1.
44. Eibel, R., P. Herzog, O. Dietrich, C. T. Rieger, H. Ostermann, M. F. Reiser, and S. O. Schoenberg. 2006. Pulmonary abnormalities in immunocompromised patients: comparative detection with parallel acquisition MR imaging and thin-section helical CT. Radiology 241:880-891.
45. el Esper, I., V. Dacquet, J. Paillard, G. Bascoulergue, M. M. Tahon, and J. Fonroget. 1992. 99Tcm-HMPAO-labelled leucocyte scintigraphy in suspected chronic osteomyelitis related to an orthopaedic device: clinical usefulness. Nucl. Med. Commun. 13:799-805.
46. Elgazzar, A. H., H. M. Abdel-Dayem, J. D. Clark, and H. R. Maxon III. 1995. Multimodality imaging of osteomyelitis. Eur. J. Nucl. Med. 22:1043-1063.
47. Erkek, E., and E. Ayaslioglu. 2006. Fever of unknown origin as the initial presenting sign of Behcet's disease. Scand. J. Infect. Dis. 38:829-830.
48. Fukuchi, K., Y. Ishida, M. Higashi, T. Tsunekawa, H. Ogino, K. Minatoya, K. Kiso, and H. Naito. 2005. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J. Vasc. Surg. 42:919-925.
49. Fuster, D., S. Chiang, G. Johnson, L. M. Schuchter, H. Zhuang, and A. Alavi. 2004. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma? J. Nucl. Med. 45:1323-1327.
50. Goethals, I., P. Smeets, O. De Winter, and L. Noens. 2006. Focally enhanced f-18 fluorodeoxyglucose (FDG) uptake in incidentally detected pulmonary embolism on PET/CT scanning. Clin. Nucl. Med. 31:497-498.
51. Gontier, E., J. L. Alberini, M. Wartski, M. Al Nakib, C. Corone, and A. P. Pecking. 2005. Increased F-18 FDG pulmonary uptake in contrast medium aspiration on PET/CT imaging. Clin. Nucl. Med. 30:756-757.
52. Gordois, A., P. Scuffham, A. Shearer, A. Oglesby, and J. A. Tobian. 2003. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care 26:1790-1795.
53. Goto, M., H. Koyama, O. Takahashi, and T. Fukui. 2007. A retrospective review of 226 hospitalized patients with fever. Intern. Med. 46:17-22.
54. Gratz, S., T. M. Behr, A. Herrmann, J. Meller, M. Conrad, H. Zappel, and W. Becker. 1998. Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin. Nucl. Med. Commun. 19:1037-1045.
55. Guglielmi, A. N., B. Y. Kim, B. Bybel, and N. Slifkin. 2006. False-positive uptake of FDG in hepatic sarcoidosis. Clin. Nucl. Med. 31:175.
56. Guhlmann, A., D. Brecht-Krauss, G. Suger, G. Glatting, J. Kotzerke, L. Kinzl, and S. N. Reske. 1998. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 206:749-754.
57. Guhlmann, A., D. Brecht-Krauss, G. Suger, G. Glatting, J. Kotzerke, L. Kinzl, and S. N. Reske. 1998. Fluorine-18-FDG PET and technctium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J. Nucl. Med. 39:2145-2152.
58. Gungor, T., I. Engel-Bicik, G. Eich, U. V. Willi, D. Nadal, J. P. Hossle, R. A. Seger, and H. C. Steinert. 2001. Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2- deoxy-D-glucose in children with chronic granulomatous disease. Arch. Dis. Child. 85:341-345.
59. Hakim, S. G., C. W. Bruecker, H. Jacobsen, D. Hermes, I. Lauer, S. Eckerle, A. Froehlich, and P. Sieg. 2006. The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible. Int. J. Oral Maxillofac. Surg. 35:809-816.
60. Handmaker, H., and R. Leonards. 1976. The bone scan in inflammatory osseous disease. Semin. Nucl. Med. 6:95-105.
61. Hara, M., P. C. Goodman, and R. A. Leder. 1999. FDG-PET finding in early-phase Takayasu arteritis. J. Comput. Assist. Tomogr. 23:16-28.
62. Hartmann, A., K. Eid, C. Dora, O. Trentz, G. K. von Schulthess, and K. D. Stumpe. 2006. Diagnostic value of (18)F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur. J. Nucl. Med. Mol. Imaging 34:704-714.
63. Heald, A. E., J. M. Hoffman, J. A. Bartlett, and H. A. Waskin. 1996. Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). Int. J. STD AIDS 7:337-346.
64. Ho, L., J. Seto, and H. Jadvar. 2006. Actinomycosis mimicking anastomotic recurrent esophageal cancer on PET-CT. Clin. Nucl. Med. 31:646-647.
65. Hoffman, J. M., and R. E. Coleman. 1995. Differentiating cerebral lymphoma from nonmalignant central nervous system lesions in patients with AIDS. Am. J. Neuroradiol. 16:1562-1563.
66. Hopfner, S., C. Krolak, S. Kessler, R. Tiling, K. Brinkbaumer, K. Hahn, and S. Dresel. 2004. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 25:890-895.
67. Huang, S. S., J. Q. Yu, W. Chamroonrat, A. Alavi, and H. Zhuang. 2006. Achilles tendonitis detected by FDG-PET. Clin. Nucl. Med. 31:147-148.
68. Isasi, C. R., P. Lu, and M. D. Blaufox. 2005. A metaanalysis of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography in the staging and restaging of patients with lymphoma. Cancer 104:1066-1074.
69. Isasi, C. R., R. M. Moadel, and M. D. Blaufox. 2005. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res. Treat. 90:105-112.
70. Jacene, H. A., V. Stearns, and R. L. Wahl. 2006. Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT. Clin. Nucl. Med. 31:379-381.
71. Jaruskova, M., and O. Belohlavek. 2006. Role of FDG-PET and PET/CT in the diagnosis of prolonged febrile states. Eur. J. Nucl. Med. Mol. Imaging 33:913-918.
72. Jones-Jackson, L., R. Walker, G. Purnell, S. G. McLaren, R. A. Skinner, J. R. Thomas, L. J. Suva, E. Anaissie, M. Miceli, C. L. Nelson, E. J. Ferris, and M. S. Smeltzer. 2005. Early detection of bone infection and differentiation from post-surgical inflammation using 2-deoxy-2-[18F]-fluoro-D- glucose positron emission tomography (FDG-PET) in an animal model. J. Orthop. Res. 23:1484-1489.
73. Kaiser, S., H. Jacobsson, and G. Hirsch. 2001. Specific or superfluous? Doubtful clinical value of granulocyte scintigraphy in osteomyelitis in children. J. Pediatr. Orthop. B 10:109-112.
74. Kalicke, T., A. Schmitz, J. H. Risse, S. Arens, E. Keller, M. Hansis, O. Schmitt, H. J. Biersack, and F. Grunwald. 2000. Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases. Eur. J. Nucl. Med. 27:524-528.
75. Kaneta, T., T. Hakamatsuka, T. Yamada, K. Takase, A. Sato, S. Higano, H. Ito, H. Fukuda, S. Takahashi, and S. Yamada. 2006. Atlantoaxial osteoarthritis in rheumatoid arthritis: FDG PET/CT findings. Clin. Nucl. Med. 31:209.
76. Kavanagh, J. J., L. Gordon, N. S. Curry, and J. G. Ravenel. 2006. Calyceal diverticulum mimicking a renal tumor on FDG PET imaging. Clin. Nucl. Med. 31:301-302.
77. Kawai, S., E. Ikeda, M. Sugiyama, J. Matsumoto, T. Higuchi, H. Zhang, N. Khan, K. Tomiyoshi, T. Inoue, H. Yamaguchi, K. Katakura, K. Endo, H. Matsuda, and M. Suzuki. 2006. Enhancement of splenic glucose metabolism during acute malarial infection: correlation of findings of FDG-PET imaging with pathological changes in a primate model of severe human malaria. Am. J. Trop. Med. Hyg. 74:353-360.
78. Keidar, Z., A. Engel, S. Nitecki, R. Bar Shalom, A. Hoffman, and O. Israel. 2003. PET/CT using 2-deoxy-2-[18F]fluoro-D-glucose for the evaluation of suspected infected vascular graft. Mol. Imaging Biol. 5:23-25.
79. Keidar, Z., D. Militianu, E. Melamed, R. Bar-Shalom, and O. Israel. 2005. The diabetic foot: initial experience with 18F-FDG PET/CT. J. Nucl. Med. 46:444-449.
80. Kitazono, M. T., and P. M. Colletti. 2006. FDG PET imaging of acute cholecystitis. Clin. Nucl. Med. 31:23-24.
81. Knockaert, D. C., L. A. Mortelmans, M. C. De Roo, and H. J. Bobbaers. 1994. Clinical value of gallium-67 scintigraphy in evaluation of fever of unknown origin. Clin. Infect. Dis. 18:601-605.
82. Koff, S. G., J. R. Sterbis, J. M. Davison, and J. L. Montilla-Soler. 2006. A unique presentation of appendicitis: F-18 FDG PET/CT. Clin. Nucl. Med. 31:704-706.
83. Koo, C. W., P. Bhargava, V. Rajagopalan, M. Ghesani, H. Sims-Childs, and N. J. Kagetsu. 2006. Incidental detection of clinically occult pituitary adenoma on whole-body FDG PET imaging. Clin. Nucl. Med. 31:42-43.
84. Koort, J. K., T. J. Makinen, J. Knuuti, J. Jalava, and H. T. Aro. 2004. Comparative 18F-FDG PET of experimental Staphylococcus aureus osteomyelitis and normal bone healing. J. Nucl. Med. 45:1406-1411.
85. Kraemer, W. J., R. Saplys, J. P. Waddell, and J. Morton. 1993. Bone scan, gallium scan, and hip aspiration in the diagnosis of infected total hip arthroplasty. J. Arthroplasty 8:611-616.
86. Krupnick, A. S., J. V. Lombardi, F. H. Engels, D. Kreisel, H. Zhuang, A. Alavi, and J. P. Carpenter. 2003. 18-Fluorodeoxyglucose positron emission tomography as a novel imaging tool for the diagnosis of aortoenteric fistula and aortic graft infection - a case report. Vasc. Endovasc. Surg. 37:363-366.
87. Kubota, R., S. Yamada, K. Kubota, K. Ishiwata, N. Tamahashi, and T. Ido. 1992. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J. Nucl. Med. 33:1972-1980.
88. Kumar, R., Y. Xiu, S. Potenta, A. Mavi, H. Zhuang, J. Q. Yu, T. Dhurairaj, S. Dadparvar, and A. Alavi. 2004. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. J. Nucl. Med. 45:1796-1803.
89. Kumar, R., Y. Xiu, J. Q. Yu, A. Takalkar, G. El-Haddad, S. Potenta, J. Kung, H. Zhuang, and A. Alavi. 2004. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J. Nucl. Med. 45:2058-2062.
90. Langen, K. J., U. Braun, E. R. Kops, H. Herzog, T. Kuwert, B. Nebeling, and L. E. Feinendegen. 1993. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J. Nucl. Med. 34:355-359.
91. Lewis, P. J., and A. Salama. 1994. Uptake of fluorine-18- fluorodeoxyglucose in sarcoidosis. J. Nucl. Med. 35:1647-1649.
92. Li, Y. J., Y. Zhang, S. Gao, and R. J. Bai. 2007. Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT. Clin. Nucl. Med. 32:262-264.
93. Lin, E. 2006. FDG PET appearance of a postpartum uterus. Clin. Nucl. Med. 31:159-160.
94. Lin, W. Y., S. C. Tsai, and G. U. Hung. 2005. FDG-PET findings in barium aspiration. Clin. Nucl. Med. 30:331-332.
95. Lindholm, P., S. Leskinen-Kallio, H. Minn, J. Bergman, M. Haaparanta, P. Lehikoinen, K. Nagren, U. Ruotsalainen, M. Teras, and H. Joensuu. 1993. Comparison of fluorine-18-fluorodeoxyglucose and carbon-11-methionine in head and neck cancer. J. Nucl. Med. 34:1711-1716.
96. Lipsky, B. A. 2004. A report from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab. Res. Rev. 20(Suppl. 1):S68-S77.
97. Listernick, R. 2006. A 17-month-old boy with fever of unknown origin. Pediatr. Ann. 35:152, 154, 156-158.
98. Lorenzen, J., R. Buchert, and K. H. Bohuslavizki. 2001. Value of FDG PET in patients with fever of unknown origin. Nucl. Med. Commun. 22:779-783.
99. Love, C., S. E. Marwin, M. B. Tomas, E. S. Krauss, G. G. Tronco, K. K. Bhargava, K. J. Nichols, and C. J. Palestro. 2004. Diagnosing infection in the failed joint replacement: a comparison of coincidence detection 18F-FDG and 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging. J. Nucl. Med. 45:1864-1871.
100. Mackie, G. C., and J. M. Pohlen. 2005. Mediastinal histoplasmosis: F-18 FDG PET and CT findings simulating malignant disease. Clin. Nucl. Med. 30:633-635.
101. Mahfouz, T., M. H. Miceli, F. Saghafifar, S. Stroud, L. Jones-Jackson, R. Walker, M. L. Grazziutti, G. Purnell, A. Fassas, G. Tricot, B. Barlogie, and E. Anaissie. 2005. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J. Clin. Oncol. 23:7857-7863.
102. Mascarenhas, N. B., D. Lam, G. R. Lynch, and R. E. Fisher. 2006. PET imaging of cerebral and pulmonary Nocardia infection. Clin. Nucl. Med. 31:131-133.
103. Matin, P. 1979. The appearance of bone scans following fractures, including immediate and long-term studies. J. Nucl. Med. 20:1227-1231.
104. Maugeri, D., A. Santangelo, S. Abbate, I. Rizza, A. Calanna, A. Lentini, M. Malaguarnera, S. Speciale, M. Testai, and P. Panebianco. 2001. A new method for diagnosing fever of unknown origin (FUO) due to infection of muscular-skeletal system in elderly people: leukoscan Tc-99m labelled scintigraphy. Eur. Rev. Med. Pharmacol. Sci. 5:123-126.
105. Meirelles, G. S., G. Ravizzini, H. W. Yeung, and T. Akhurst. 2006. Esophageal leiomyoma: a rare cause of false-positive FDG scans. Clin. Nucl. Med. 31:342-344.
106. Meller, J., G. Altenvoerde, U. Munzel, A. Jauho, M. Behe, S. Gratz, H. Luig, and W. Becker. 2000. Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur. J. Nucl. Med. 27:1617-1625.
107. Meller, J., V. Ivancevic, M. Conrad, S. Gratz, D. L. Munz, and W. Becker. 1998. Clinical value of immunoscintigraphy in patients with fever of unknown origin. J. Nucl. Med. 39:1248-1253.
108. Meller, J., G. Koster, T. Liersch, U. Siefker, K. Lehmann, I. Meyer, K. Schreiber, G. Altenvoerde, and W. Becker. 2002. Chronic bacterial osteomyelitis: prospective comparison of (18)F-FDG imaging with a dual-head coincidence camera and (111)In-labelled autologous leucocyte scintigraphy. Eur. J. Nucl. Med. Mol. Imaging 29:53-60.
109. Meller, J., F. Strutz, U. Siefker, A. Scheel, C. O. Sahlmann, K. Lehmann, M. Conrad, and R. Vosshenrich. 2003. Early diagnosis and follow-up of aortitis with [(18)F]FDG PET and MRI. Eur. J. Nucl. Med. Mol. Imaging 30:730-736.
110. Miceli, M. H., L. B. J. Jackson, R. C. Walker, G. Talamo, B. Barlogie, and E. J. Anaissie. 2004. Diagnosis of infection of implantable central venous catheters by [18F]fluorodeoxyglucose positron emission tomography. Nucl. Med. Commun. 25:813-818.
111. Miyamoto, M., E. F. Sato, M. Nishikawa, Y. Nishizawa, H. Morii, and M. Inoue. 2003. Effect of endogenously generated nitric oxide on the energy metabolism of peritoneal macrophages. Physiol. Chem. Phys. Med. NMR 35:1-11.
112. Mudun, A., S. Unal, R. Aktay, S. Akmehmet, and S. Cantez. 1995. Tc-99m nanocolloid and Tc-99m MDP three-phase bone imaging in osteomyelitis and septic arthritis. A comparative study. Clin. Nucl. Med. 20:772-778.
113. Mumme, T., P. Reinartz, J. Alfer, R. Muller-Rath, U. Buell, and D. C. Wirtz. 2005. Diagnostic values of positron emission tomography versus triple-phase bone scan in hip arthroplasty loosening. Arch. Orthop. Trauma Surg. 125:322-329.
114. Nguyen, B. D. 2006. F-18 FDG PET/CT imaging of disseminated coccidioidomycosis. Clin. Nucl. Med. 31:568-571.
115. Nguyen, B. D., and S. F. Chivers. 2006. Tear of plantar fascia and tibiocalcaneal ligament with positive F-18 FDG PET findings. Clin. Nucl. Med. 31:709-712.
116. Niamane, R., M. K. Moudden, M. Zyani, and A. Hda. 2005. Protracted fever of unknown origin as the presenting symptom of Behcet's disease. Report of a case. Joint Bone Spine 72:175-176.
117. O'Doherty, M. J., S. F. Barrington, M. Campbell, J. Lowe, and C. S. Bradbeer. 1997. PET scanning and the human immunodeficiency virus-positive patient. J. Nucl. Med. 38:1575-1583.
118. Oudjhane, K., and E. M. Azouz. 2001. Imaging of osteomyelitis in children. Radiol. Clin. N. Am. 39:251-266.
119. Oyen, W. J., R. A. Claessens, J. M. Raemaekers, B. E. de Pauw, J. W. van der Meer, and F. H. Corstens. 1992. Diagnosing infection in febrile granulocytopenic patients with indium-111-labeled human immunoglobulin G. J. Clin. Oncol. 10:61-68.
120. Ozsahin, H., M. von Planta, I. Muller, H. C. Steinert, D. Nadal, R. Lauener, P. Tuchschmid, U. V. Willi, M. Ozsahin, N. E. Crompton, and R. A. Seger. 1998. Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 92:2719-2724.
121. Palestro, C. J., C. K. Kim, A. J. Swyer, J. D. Capozzi, R. W. Solomon, and S. J. Goldsmith. 1990. Total-hip arthroplasty: periprosthetic indium-111-labeled leukocyte activity and complementary technetium-99m-sulfur colloid imaging in suspected infection. J. Nucl. Med. 31:1950-1955.
122. Palestro, C. J., C. K. Kim, A. J. Swyer, S. Vallabhajosula, and S. J. Goldsmith. 1991. Radionuclide diagnosis of vertebral osteomyelitis: indium-111-leukocyte and technetium-99m-methylene diphosphonate bone scintigraphy. J. Nucl. Med. 32:1861-1865.
123. Palestro, C. J., and M. A. Torres. 1997. Radionuclide imaging in orthopedic infections. Semin. Nucl. Med. 27:334-345.
124. Patrikeos, A., W. Breidahl, and P. Robins. 2005. F-18 FDG uptake associated with elastofibroma dorsi. Clin. Nucl. Med. 30:617-618.
125. Peters, A. M. 1999. Nuclear medicine imaging in fever of unknown origin. Q. J. Nucl. Med. 43:61-73.
126. Petersdorf, R. G. 1992. Fever of unknown origin. An old friend revisited. Arch. Intern. Med. 152:21-22.
127. Petersdorf, R. G., and P. B. Beeson. 1961. Fever of unexplained origin: report on 100 cases. Medicine (Baltimore) 40:1-30.
128. Porter, S. B., and M. A. Sande. 1992. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327:1643-1648.
129. Prvulovich, E. M., R. F. Miller, D. C. Costa, A. Severn, E. Corbett, J. Bomanji, W. S. Becker, and P. J. Ell. 1995. Immunoscintigraphy with a 99Tcm-labelled anti-granulocyte monoclonal antibody in patients with human immunodeficiency virus infection and AIDS. Nucl. Med. Commun. 16:838-845.
130. Rao, B. R., J. W. Winebright, and J. Bartow. 1980. Value of total-body bone scan in a child with osteomyelitis. Clin. Nucl. Med. 5:559.
131. Reddy, M. P., and M. R. Ramaswamy. 2005. FDG uptake in brown adipose tissue mimicking an adrenal metastasis: source of false-positive interpretation. Clin. Nucl. Med. 30:257-258.
132. Reif, A. E., V. R. Potter, and G. A. Lepage. 1953. Aerobic glycolysis in homogenates of normal and tumor tissues. Cancer Res. 13:807-816.
133. Reinartz, P., T. Mumme, B. Hermanns, U. Cremerius, D. C. Wirtz, W. M. Schaefer, F. U. Niethard, and U. Buell. 2005. Radionuclide imaging of the painful hip arthroplasty: positron-emission tomography versus triple-phase bone scanning. J. Bone Joint Surg. Br. 87:465-470.
134. Reuter, S., A. Buck, B. Manfras, W. Kratzer, H. M. Seitz, K. Darge, S. N. Reske, and P. Kern. 2004. Structured treatment interruption in patients with alveolar echinococcosis. Hepatology 39:509-517.
135. Reuter, S., H. Schirrmeister, W. Kratzer, C. Dreweck, S. N. Reske, and P. Kern. 1999. Pericystic metabolic activity in alveolar echinococcosis: assessment and follow-up by positron emission tomography. Clin. Infect. Dis. 29:1157-1163.
136. Rohde, H., M. A. Horstkotte, S. Loeper, J. Aberle, L. Jenicke, R. Lampidis, and D. Mack. 2004. Recurrent Listeria monocytogenes aortic graft infection: confirmation of relapse by molecular subtyping. Diagn. Microbiol. Infect. Dis. 48:63-67.
137. Rojas-Burke, J. 1992. Health officials reacting to infection mishaps. J. Nucl. Med. 33:13N-14N, 27N.
138. Rozin, A. P., R. Bar-Shalom, A. Strizevsky, and G. Jacob. 2007. Fever due to aortitis. Clin. Rheumatol. 26:265-267.
139. Sahlmann, C. O., U. Siefker, K. Lehmann, and J. Meller. 2004. Dual time point 2-[18F]fluoro-2′-deoxyglucose positron emission tomography in chronic bacterial osteomyelitis. Nucl. Med. Commun. 25:819-823.
140. Salhab, K. F., D. Baram, and T. V. Bilfinger. 2006. Growing PET positive nodule in a patient with histoplasmosis: case report. J. Cardiothorac. Surg. 1:23.
141. Scharko, A. M., S. B. Perlman, R. W. Pyzalski, F. M. Graziano, J. Sosman, and C. D. Pauza. 2003. Whole-body positron emission tomography in patients with HIV-1 infection. Lancet 362:959-961.
142. Scher, D. M., K. Pak, J. H. Lonner, J. E. Finkel, J. D. Zuckerman, and P. E. Di Cesare. 2000. The predictive value of indium-111 leukocyte scans in the diagnosis of infected total hip, knee, or resection arthroplasties. J. Arthroplasty 15:295-300.
143. Schinabeck, M. K., and J. L. Johnson. 2005. Osteomyelitis in diabetic foot ulcers. Prompt diagnosis can avert amputation. Postgrad. Med. 118:11-15.
144. Schmitz, A., H. J. Risse, T. Kalicke, F. Grunwald, and O. Schmitt. 2000. FDG-PET for diagnosis and follow-up of inflammatory processes: initial results from the orthopedic viewpoint. Z. Orthop. Ihre. Grenzgeb. 138:407-412. (In German.)
145. Schmitz, A., J. H. Risse, J. Textor, D. Zander, H. J. Biersack, O. Schmitt, and H. Palmedo. 2002. FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos. Int. 13:755-761.
146. Shie, P., I. Farukhi, R. S. Hughes, and O. K. Oz. 2007. Round pneumonia mimicking pulmonary malignancy on F-18 FDG PET/CT. Clin. Nucl. Med. 32:55-56.
147. Short, S., P. Hoskin, and W. Wong. 2005. Ovulation and increased FDG uptake on PET: potential for a false-positive result. Clin. Nucl. Med. 30:707.
148. Siosteen, A. K., F. Celsing, and H. Jacobsson. 2005. FDG uptake in a catheter-related thrombus simulating relapse of lymphoma. Clin. Nucl. Med. 30:338-339.
149. Sonmezoglu, K., M. Sonmezoglu, M. Halac, I. Akgun, C. Turkmen, C. Onsel, B. Kanmaz, K. Solanki, K. E. Britton, and I. Uslu. 2001. Usefulness of 99mTc-ciprofloxacin (Infecton) scan in diagnosis of chronic orthopedic infections: comparative study with 99mTc-HMPAO leukocyte scintigraphy. J. Nucl. Med. 42:567-574.
150. Sorbara, L. R., F. Maldarelli, G. Chamoun, B. Schilling, S. Chokekijcahi, L. Staudt, H. Mitsuya, I. A. Simpson, and S. L. Zeichner. 1996. Human immunodeficiency virus type 1 infection of H9 cells induces increased glucose transporter expression. J. Virol. 70:7275-7279.
151. Stokkel, M. P., H. E. Reigman, and E. K. Pauwels. 2002. Scintigraphic head-to-head comparison between 99mTc-WBCs and 99mTc-LeukoScan in the evaluation of inflammatory bowel disease: a pilot study. Eur. J. Nucl. Med. Mol. Imaging 29:251-254.
152. Stumpe, K. D., H. Dazzi, A. Schaffner, and G. K. von Schulthess. 2000. Infection imaging using whole-body FDG-PET. Eur. J. Nucl. Med. 27:822-832.
153. Stumpe, K. D., H. P. Notzli, M. Zanetti, E. M. Kamel, T. F. Hany, G. W. Gorres, G. K. von Schulthess, and J. Hodler. 2004. FDG PET for differentiation of infection and aseptic loosening in total hip replacements: comparison with conventional radiography and three-phase bone scintigraphy. Radiology 231:333-341.
154. Stumpe, K. D., E. C. Renner-Schneiter, A. K. Kuenzle, F. Grimm, Z. Kadry, P. A. Clavien, P. Deplazes, G. K. von Schulthess, B. Muellhaupt, R. W. Ammann, and E. L. Renner. 2007. F-18-fluorodeoxyglucose (FDG) positron-emission tomography of Echinococcus multilocularis liver lesions: prospective evaluation of its value for diagnosis and follow-up during benzimidazole therapy. Infection 35:11-18.
155. Sturm, E., E. H. Rings, E. H. Scholvinck, A. S. Gouw, R. J. Porte, and J. Pruim. 2006. Fluordeoxyglucose positron emission tomography contributes to management of pediatric liver transplantation candidates with fever of unknown origin. Liver Transpl. 12:1698-1704.
156. Sugawara, Y., D. K. Braun, P. V. Kison, J. E. Russo, K. R. Zasadny, and R. L. Wahl. 1998. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur. J. Nucl. Med. 25:1238-1243.
157. Syrjala, M. T., V. Valtonen, K. Liewendahl, and G. Myllyla. 1987. Diagnostic significance of indium-111 granulocyte scintigraphy in febrile patients. J. Nucl. Med. 28:155-160.
158. Termaat, M. F., P. G. Raijmakers, H. J. Scholten, F. C. Bakker, P.
159. Vos, F. J., C. P. Bleeker-Rovers, A. P. van Dijk, and W. J. Oyen. 2006. Detection of pacemaker and lead infection with FDG-PET. Eur. J. Nucl. Med. Mol. Imaging 33:1245.
160. Wahl, R. L., C. A. Henry, and S. P. Ethier. 1992. Serum glucose: effects on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D- glucose in rodents with mammary carcinoma. Radiology 183:643-647.
161. Wang, K. B., G. U. Hung, and W. Y. Lin. 2006. Extraordinarily high F-18 FDG uptake caused by a pleomorphic adenoma of the parotid gland. Clin. Nucl. Med. 31:638-639.
162. Warburg, O. 1930. The metabolism of tumors. Constable, London, United Kingdom.
163. Wasyliw, C. W., and V. J. Caride. 2005. Incidental detection of bilateral elastofibroma dorsi with F-18 FDG PET/CT. Clin. Nucl. Med. 30:700-701.
164. Williams, D. T., J. R. Hilton, and K. G. Harding. 2004. Diagnosing foot infection in diabetes. Clin. Infect. Dis. 39(Suppl. 2):S83-S86.
165. Williams, G., R. M. Joyce, and J. A. Parker. 2006. False-positive axillary lymph node on FDG-PET/CT scan resulting from immunization. Clin. Nucl. Med. 31:731-732.
166. Win, Z., E. O'Flynn, E. J. O'Rourke, A. Singh, G. S. Cooke, J. S. Friedland, and A. Al-Nahhas. 2006. F-18 FDG PET in the diagnosis and monitoring of Salmonella vertebral osteomyelitis: a comparison with MRI. Clin. Nucl. Med. 31:437-440.
167. Win, Z., J. Todd, and A. Al-Nahhas. 2005. FDG-PET imaging in Pneumocystis carinii pneumonia. Clin. Nucl. Med. 30:690-691.
168. Wyss, M. T., M. Honer, N. Spath, J. Gottschalk, S. M. Ametamey, B. Weber, G. K. von Schulthess, A. Buck, and A. H. Kaim. 2004. Influence of ceftriaxone treatment on FDG uptake - an in vivo [18F]-fluorodeoxyglucose imaging study in soft tissue infections in rats. Nucl. Med. Biol. 31:875-882.
169. Xiu, Y., C. Bhutani, J. Q. Yu, T. Dhurairaj, S. Dadparvar, S. Reddy, R. Kumar, H. Yang, A. Alavi, and H. Zhuang. 2007. Dual-time point FDG-PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity. Clin. Nucl. Med. 31:101-105.
170. Xiu, Y., J. Q. Yu, E. Cheng, R. Kumar, A. Alavi, and H. Zhuang. 2005. Sarcoidosis demonstrated by FDG PET imaging with negative findings on gallium scintigraphy. Clin. Nucl. Med. 30:193-195.
171. Yamada, S., K. Kubota, R. Kubota, T. Ido, and N. Tamahashi. 1995. High accumulation of nuorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J. Nucl. Med. 36:1301-1306.
172. Yap, K. K., T. H. Saunder, and A. Poon. 2005. Increased F-18 FDG skeletal muscle uptake secondary to altered weight bearing and the use of crutches. Clin. Nucl. Med. 30:806-807.
173. Yu, J. Q., J. W. Kung, S. Potenta, Y. Xiu, A. Alavi, and H. Zhuang. 2004. Chronic cholecystitis detected by FDG-PET. Clin. Nucl. Med. 29:496-497.
174. Yuh-Feng, T., W. Chin-Chu, S. Cheng-Tau, and T. Min-Tsung. 2005. FDG PET CT features of an intraabdominal gossypiboma. Clin. Nucl. Med. 30:561-563.
175. Zhuang, H., and A. Alavi. 2002. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin. Nucl. Med. 32:47-59.
176. Zhuang, H., T. K. Chacko, M. Hickeson, K. Stevenson, Q. Feng, F. Ponzo, J. P. Garino, and A. Alavi. 2002. Persistent non-specific FDG uptake on PET imaging following hip arthroplasty. Eur. J. Nucl. Med. Mol. Imaging 29:1328-1333.
177. Zhuang, H., P. S. Duarte, M. Pourdehand, D. Shnier, and A. Alavi. 2000. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging. Clin. Nucl. Med. 25:281-284.
178. Zhuang, H., P. S. Duarte, M. Pourdehand, A. Maes, F. Van Acker, D. Shnier, J. P. Garino, R. H. Fitzgerald, and A. Alavi. 2001. The promising role of 18F-FDG PET in detecting infected lower limb prosthesis implants. J. Nucl. Med. 42:44-48.
179. Zhuang, H., P. S. Duarte, A. Rebenstock, Q. Feng, and A. Alavi. 2003. Pulmonary Clostridium perfringens infection detected by FDG positron emission tomography. Clin. Nucl. Med. 28:517-518.
180. Zhuang, H., R. Kumar, S. Mandel, and A. Alavi. 2004. Investigation of thyroid, head, and neck cancers with PET. Radiol. Clin. N. Am. 42:1101-1111.
181. Zhuang, H., M. Pourdehnad, E. S. Lambright, A. J. Yamamoto, M. Lanuti, P. Li, P. D. Mozley, M. D. Rossman, S. M. Albelda, and A. Alavi. 2001. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J. Nucl. Med. 42:1412-1417.
182. Zhuang, H., J. W. Sam, T. K. Chacko, P. S. Duarte, M. Hickeson, Q. Feng, K. Z. Nakhoda, L. Guan, P. Reich, S. M. Altimari, and A. Alavi. 2003. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur. J. Nucl. Med. Mol. Imaging 30:1096-1103.
183. Zhuang, H., J. Q. Yu, and A. Alavi. 2005. Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders. Radiol. Clin. N. Am. 43:121-134.
184. Zhuang, H. M., A. Cortes-Blanco, M. Pourdehnad, L. E. Adam, A. J. Yamamoto, R. Martinez-Lazaro, J. H. Lee, J. C. Loman, M. D. Rossman, and A. Alavi. 2001. Do high glucose levels have differential effect on FDG uptake in inflammatory and malignant disorders? Nucl. Med. Commun. 22:1123-1128.